OPTIC PATHWAY GLIOMA
Clinical trials for OPTIC PATHWAY GLIOMA explained in plain language.
Never miss a new study
Get alerted when new OPTIC PATHWAY GLIOMA trials appear
Sign up with your email to follow new studies for OPTIC PATHWAY GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug TURALIO takes on tough childhood cancers in early trial
Disease control Recruiting nowThis early-phase study tests the drug TURALIO (pexidartinib) in people aged 3 to 35 whose cancer has not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors or control leukemia. Participants take a daily capsule for up to 2 years, wit…
Matched conditions: OPTIC PATHWAY GLIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New proton therapy aims to shield memory in kids with brain cancer
Disease control Recruiting nowThis study tests a new way to give proton radiation to children with low-grade glioma, a common brain tumor. The goal is to avoid the hippocampus, a brain area key for memory, to reduce long-term memory loss. About 74 children will receive this targeted radiation, and researchers…
Matched conditions: OPTIC PATHWAY GLIOMA
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC